Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

MabVax and Telik merge

Executive Summary

MabVax Therapeutics Inc. (antibody-based cancer treatments) and public oncology drug company Telik Inc. agreed to merge and form one cancer immunotherapy drug discovery firm that will be 85%-owned by MabVax shareholders.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Reverse Acquisition

Related Companies

UsernamePublicRestriction

Register